New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
07:06 EDTBLRXBioLineRx in-licenses BL-1110 for treatment of neuropathic pain
BioLineRx announced that it has in-licensed BL-1110, a novel compound for the treatment of neuropathic pain. BL-1110 may also be developed for the treatment of scleroderma, an autoimmune disease characterized by a hardening and tightening of the skin and connective tissues. The compound, which had been previously developed as part of BioLineRx’s Early Development Program under the name EDP-34, was in-licensed from the University of Colorado.
News For BLRX From The Last 14 Days
Check below for free stories on BLRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
07:03 EDTBLRXBioLineRx receives Notice of Allowance for BL-7010 U.S. patent
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use